HLA-C and neoplasm: Considering the overall expression data, pathways such as “MHC class II protein complex binding” and “MHC protein complex binding” were validated through GSEA, indicating their critical roles in the molecular landscape of the disease, potentially linked to increased immune evasion of the tumor.